HLA-A and neoplasm: Allogeneic HLA-A*02:01 pDCs can induce melanoma antigen-specific and functional cytotoxic T cell responses ex vivo and have been shown to inhibit tumor growth in a humanized mouse model (Aspord et al., 2010, 2012).